Diagnostic Impact of Shear Wave Elastography in Patients with Heart Failure

Diagnostic Impact of Shear Wave Elastography in Patients with Heart Failure - GE-Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00008837

Enrollment

Registered

2015-07-22

Start date

2015-06-26

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteer I50.12 I50.13 I50.14

Interventions

Group 1: patients with heart fialure undergoing an ultrasound diagnosis. The standard ultrasound examination with echo intensity and gray scale imaging is done, additionally the innovative SWE (Shear

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Heart failure, cadiac recompensation at rest

Exclusion criteria

Exclusion criteria: state of exhaustion, pAVK II - IV, peripheral nerve lesion, central paresis, gonarthrosis, coxarthrosis, borreliosis, radiculitis, malignant tumour, pneumonia with obligate oxygen administration, severe respiratory disease (not treated), Infection with CRP > 100, severe anemia (Hb < 8.5 g/dl)

Design outcomes

Primary

Measure	Time frame
Sensitivity and Specificity of SWE (shear wave elastography) in comparison to EI and B-Scan (Brightness) Ultrasound gray scale imaging	—

Countries

Germany

Contacts

Public ContactChristoph Hehrlein

Klinik für Kardiologie und Angiologie I Universitäts-Herzzentrum Freiburg Bad-Krozingen

christoph.hehrlein@universitaets-herzzentrum.de0761-270-77090

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026